Complaints on hip implants continue piling up at the U.S. Food and Drug Administration (FDA) with 5,000 of them added this year alone. Some 75 percent of those claims involved the hip replacement systems of DePuy Orthopaedics Inc., a subsidiary of Johnson & Johnson. Several of those lawsuits have been consolidated into a multidistrict litigation (MDL), making it easier for initiating a hip replacement case. Due to the growing evidence against them, the British Hip Society has called for an in...